Background Adherence to highly active antiretroviral therapy (HAART) for human
immunodeficiency syndrome type 1 (HIV-1) infection is essential to sustain viral suppression …

OBJECTIVE: Adherence to complex antiretroviral therapy (ART) is critical for HIV treatment
but difficult to achieve. The development of interventions to improve adherence requires …

Background: Combination antiretroviral therapy with protease inhibitors has transformed HIV
infection from a terminal condition into one that is manageable. However, the complexity of …

Purpose A lower daily pill burden may improve adherence to antiretroviral treatment (ART)
and clinical outcomes in patients with human immunodeficiency virus (HIV). This study …

Background Poor adherence to medication limits the effectiveness of treatment for human
immunodeficiency virus. Systematic reviews can identify practical and effective interventions …

OBJECTIVE: Adherence to combination antiretroviral therapy is critical for clinical and
virologic success in HIV-infected patients. To combat poor adherence, clinicians must …

Background. Adherence of 95% or greater to highly active combination antiretroviral therapy
is generally considered necessary to achieve optimal virologic suppression in HIV-infected …

Background: Poor adherence to HIV protease inhibitors may compromise the effectiveness
of treatment. Few studies have compared methods for measuring adherence or have related …

Objective: Adherence to antiretroviral therapies (ART) is the strongest predictor of viral
suppression among individuals infected with HIV, however, limited data exists to understand …

Objective Drug adherence is crucial to the success of highly active antiretroviral therapy
(HAART) in the treatment of HIV disease. Adherence to HAART and its determinants may …